Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ureaplasma parvum DNA represents the genetic material of a wall-less bacterium that is a common member of the human urogenital microbiota [StatPearls, 2023]. This circular, double-stranded DNA molecule encodes the essential biological instructions for the organism, including the urease enzyme complex which is critical for its survival and energy production through urea hydrolysis [PubMed, 2020]. While often existing as a commensal, the presence and replication of U. parvum DNA are associated with several inflammatory conditions, such as non-gonococcal urethritis, cervicitis, and adverse pregnancy outcomes like preterm labor [NIH, 2022]. The DNA itself serves as the primary target for diagnostic molecular assays, such as quantitative PCR, which identify specific sequences like the 16S rRNA or urease genes to confirm infection [Journal of Clinical Microbiology, 2018]. Pharmacologically, the replication and integrity of this DNA are disrupted by fluoroquinolone antibiotics, which trap DNA gyrase and topoisomerase IV on the DNA to induce lethal double-strand breaks [Nature Reviews Microbiology, 2017]. Furthermore, the DNA acts as the template for all bacterial proteins, making its expression an indirect target for macrolides and tetracyclines that inhibit the bacterial ribosome [StatPearls, 2023].
Inhibition of DNA replication and transcription through the stabilization of DNA-enzyme cleavage complexes (e.g., DNA gyrase and topoisomerase IV) or through the inhibition of protein synthesis machinery required for DNA maintenance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ureaplasma parvum DNA (U. parvum DNA).